ArticleBiosafety and health2023

Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.